Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared a post on LinkedIn:
“Elegant genetic cancer immunotherapy from yizhoudong lab Tisch Cancer Sinai Immunol mobilizing dendritic cells to teach T cells to recognize and kill tumors!”